Interobserver diagnostic variability at "moderate" agreement levels could significantly change the prognostic estimates of clinicopathologic studies: evaluation of the problem using evidence from patients with diffuse lung disease

Annals of Diagnostic Pathology

Volumn 14, Issue 2, 2010, Pages 88-93

  Marchevsky, Alberto M ^a   Gupta, Ruta ^a  

^a Cedars Sinai Medical Center   (United States)

Author keywords

Evidence based; Interobserver variability; Interstitial lung disease

Indexed keywords

ARTICLE; INTERSTITIAL PNEUMONIA; LUNG DISEASE; MATHEMATICAL ANALYSIS; OBSERVER VARIATION; PRIORITY JOURNAL; PROGNOSIS; SIMULATION; SURVIVAL;

HUMANS; LUNG DISEASES, INTERSTITIAL; OBSERVER VARIATION; PROGNOSIS;

EID: 77649311615     PISSN: 10929134     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anndiagpath.2009.12.002     Document Type: Article

References (22)

1. Marchevsky A.M., and Wick M.R. Evidence-based medicine, medical decision analysis, and pathology. Hum Pathol 35 (2004) 1179-1188
2. Katzenstein A.L., and Fiorelli R.F. Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance. Am J Surg Pathol 18 (1994) 136-147
3. Park J.H., Kim D.S., Park I.N., Jang S.J., Kitaichi M., Nicholson A.G., et al. Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes. Am J Respir Crit Care Med 175 (2007) 705-711
4. Nicholson A.G., Colby T.V., du Bois R.M., Hansell D.M., and Wells A.U. The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 162 (2000) 2213-2217
5. Riha R.L., Duhig E.E., Clarke B.E., Steele R.H., Slaughter R.E., and Zimmerman P.V. Survival of patients with biopsy-proven usual interstitial pneumonia and nonspecific interstitial pneumonia. Eur Respir J 19 (2002) 1114-1118
6. Travis W.D., Hunninghake G., King Jr. T.E., Lynch D.A., Colby T.V., Galvin J.R., et al. Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project. Am J Respir Crit Care Med 177 (2008) 1338-1347
7. Travis W.D., Gal A.A., Colby T.V., Klimstra D.S., Falk R., and Koss M.N. Reproducibility of neuroendocrine lung tumor classification. Hum Pathol 29 (1998) 272-279
8. Darvishian F., Singh B., Simsir A., Ye W., and Cangiarella J.F. Atypia on breast core needle biopsies: reproducibility and significance. Ann Clin Lab Sci 39 (2009) 270-276
9. Kaye P.V., Haider S.A., Ilyas M., James P.D., Soomro I., Faisal W., et al. Barrett's dysplasia and the Vienna classification: reproducibility, prediction of progression and impact of consensus reporting and p53 immunohistochemistry. Histopathology 54 (2009) 699-712
10. Gupta R., Marchevsky A.M., McKenna R.J., Wick M., Moran C., Zakowski M.F., et al. Evidence-based pathology and the pathologic evaluation of thymomas: transcapsular invasion is not a significant prognostic feature. Arch Pathol Lab Med 132 (2008) 926-930
11. Marchevsky A.M., Gupta R., McKenna R.J., Wick M., Moran C., Zakowski M.F., et al. Evidence-based pathology and the pathologic evaluation of thymomas: the World Health Organization classification can be simplified into only 3 categories other than thymic carcinoma. Cancer 112 (2008) 2780-2788
12. Sackett D., Straus S., Richardson W., Rosenberg W., and Haynes R. Evidence-based medicine: how to practice and teach EBM (2000), Churchill Livingstone, Edinburgh
13. Parra E.R., Kairalla R.A., de Carvalho C.R., and Capelozzi V.L. Abnormal deposition of collagen/elastic vascular fibres and prognostic significance in idiopathic interstitial pneumonias. Thorax 62 (2007) 428-437
14. Viera A.J., and Garrett J.M. Understanding interobserver agreement: the kappa statistic. Fam Med 37 (2005) 360-363
15. Flaherty K.R., Travis W.D., Colby T.V., Toews G.B., Kazerooni E.A., Gross B.H., et al. Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med 164 (2001) 1722-1727
16. Bjoraker J.A., Ryu J.H., Edwin M.K., Myers J.L., Tazelaar H.D., Schroeder D.R., et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 157 (1998) 199-203
17. Ikediobi O.N. Personalized medicine: are we there yet?. Pharmacogenomics J 9 (2009) 85
18. Burke W., and Psaty B.M. Personalized medicine in the era of genomics. JAMA 298 (2007) 1682-1684
19. Ozdemir V., Suarez-Kurtz G., Stenne R., Somogyi A.A., Someya T., Kayaalp S.O., et al. Risk assessment and communication tools for genotype associations with multifactorial phenotypes: the concept of "edge effect" and cultivating an ethical bridge between omics innovations and society. OMICS 13 (2009) 43-61
20. Berry K.J., Johnston J.E., and Mielke Jr. P.W. Weighted kappa for multiple raters. Percept Mot Skills 107 (2008) 837-848
21. Roberts C., and McNamee R. Assessing the reliability of ordered categorical scales using kappa-type statistics. Stat Methods Med Res 14 (2005) 493-514
22. Raab S.S., Robinson R.A., Jensen C.S., Ozkutlu D., O'Reilly P.O., Savell V.H., et al. Mucinous tumors of the ovary: interobserver diagnostic variability and utility of sectioning protocols. Arch Pathol Lab Med 121 (1997) 1192-1198